Erdosine Capsule 300 mg (Erdosteine)

Adult dose

Adults: Administer 300 mg of erdosteine orally 2～3 times daily. When used for acute respiratory disease, do not administer continuously for more than 10 days.

This medication should not be used in patients with known allergy to this drug or its components. Patients with cirrhosis or cystathionine synthase deficiency should avoid this drug as its metabolites may affect methionine metabolism. Patients with peptic ulcers should use caution as symptoms may worsen with this medication. Patients with severely impaired renal function, specifically those with a creatinine clearance of less than 25 mL/min, should avoid using this drug as it could be hazardous. Patients with severe liver dysfunction should also avoid this medication for safety reasons. Patients with mild to moderate liver dysfunction should use this drug with caution and ensure that the daily dose does not exceed 300 mg. Diabetics or patients on a low-calorie diet should be especially careful when taking the syrup form of this medication. This medication contains a dye called Yellow No. 5; those with allergies or hypersensitivity to this component should take extra precautions. Overdose may cause side effects such as sweating, dizziness, and facial flushing; therefore, adherence to the prescribed dosage is crucial. Side effects such as headache, cold symptoms, breathing difficulties, taste abnormalities, nausea, vomiting, diarrhea, abdominal pain, heartburn, hives, skin rash, fatigue, dyspepsia, gastro-intestinal disturbances, regurgitation, erythema nodosum, palpitations, facial swelling, itching, weakness, drowsiness, and rashes may occur. During the use of this medication, fatigue, dyspepsia, facial swelling, and itching have also been reported, though the direct correlation with this medication is not clearly established. Caution should be exercised when taking this medication with an expectorant as cough relief may hinder the expulsion of mucus from the bronchi, increasing the risk of bronchial infection. Pregnant women, women who may become pregnant, and nursing mothers should refrain from using this medication as its safety has not been sufficiently confirmed.

• sweating
• dizziness
• flushing
• headache
• cold
• dyspnea
• taste disorder
• nausea
• vomiting
• diarrhea

Drug interactions

Consult a doctor or pharmacist when taking this medication with cough medicines.

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Therefore, avoid direct sunlight, high temperatures, and humid areas until the medication is used, and store it in a cool place.

Appearance

A hard capsule with a green upper part and a pale yellow lower part, containing white powder.

Package unit

30 capsules/bottle, 100 capsules/bottle